Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.290
0.00 (0.00%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
165.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADC Therapeutics | 79.18M |
| Protalix BioTherapeutics | 76.38M |
| Spero Therapeutics | 61.19M |
| Precision BioSciences | 45.07M |
| ProQR Therapeutics | 15.73M |
| Innate Pharma | 10.57M |
| Korro Bio | 3.84M |
ABOS News
- 21 days ago - Acumen Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Acumen Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 23 days ago - Acumen Pharmaceuticals Earnings release: Q1 2026 - Filings
- 23 days ago - Acumen Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 24 days ago - Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 24 days ago - Acumen Pharmaceuticals Slides: Corporate presentation - Filings
- 4 weeks ago - Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference - GlobeNewsWire
- 4 weeks ago - Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 - GlobeNewsWire